NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
78.99 -0.01 (-0.01%) GOLD FUTURES
2,311.20 +0.20 (+0.01%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
46,956.06 +1,168.61 (+2.55%)
ARC Resources Ltd. (AETUF)
| Previous close | 17.80 |
| Open | 18.01 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 17.94 - 18.19 |
| 52-week range | 11.54 - 19.16 |
| Volume | |
| Avg. volume | 94,349 |
| Market cap | 10.842B |
| Beta (5Y monthly) | 1.33 |
| PE ratio (TTM) | 9.50 |
| EPS (TTM) | 1.91 |
| Earnings date | 07 Feb 2024 - 12 Feb 2024 |
| Forward dividend & yield | 0.49 (2.78%) |
| Ex-dividend date | 27 Mar 2024 |
| 1y target est | N/A |
- Reuters
CORRECTED-UPDATE 1-Pembina says ARC Resources will supply natgas to Cedar LNG for liquefication (April 4)
Pembina Pipeline said on Thursday it has entered into an agreement with Canadian firm ARC Resources, which will deliver about 200 million cubic feet (mmcf) per day of natural gas for liquefication to the Cedar LNG project. Under the agreement, ARC Resources will supply natural gas through the Coastal GasLink from its production base in Montney, British Columbia, for a term of 20 years commencing in 2028.
Simply Wall St.Those who invested in ARC Resources (TSE:ARX) three years ago are up 241%
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...
GlobeNewswireARC Resources Ltd. donates $5 million to OWN.CANCER Campaign ahead of opening of new Arthur J.E. Child Comprehensive Cancer Centre in Calgary
This is the campaign’s largest corporate gift and will support clinical trials and innovations in radiation oncologyCALGARY, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- The Alberta Cancer Foundation, along with Alberta Health Services (AHS) and the University of Calgary (UCalgary), are thrilled to announce that ARC Resources Ltd. (ARC) has generously donated $5 million to the OWN.CANCER campaign. This donation is the largest corporate gift made to the campaign and will support clinical trials an
